-
Je něco špatně v tomto záznamu ?
Effect of hyperbaric oxygen on the growth and susceptibility of facultatively anaerobic bacteria and bacteria with oxidative metabolism to selected antibiotics
D. Chmelař, M. Rozložník, M. Hájek, N. Pospíšilová, J. Kuzma
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
- MeSH
- ampicilin farmakologie MeSH
- anaerobní bakterie MeSH
- antibakteriální látky farmakologie MeSH
- Bacteria MeSH
- Escherichia coli MeSH
- hyperbarická oxygenace * MeSH
- Klebsiella pneumoniae MeSH
- kombinace léků trimethoprim a sulfamethoxazol farmakologie MeSH
- kyslík MeSH
- lidé MeSH
- mikrobiální testy citlivosti MeSH
- oxidační stres MeSH
- pseudomonádové infekce * MeSH
- Pseudomonas aeruginosa MeSH
- sulbaktam MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Wild strains of Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis were tested in an experimental hyperbaric chamber to determine the possible effect of hyperbaric oxygen on the susceptibility of these strains to the antibiotics ampicillin, ampicillin + sulbactam, cefazolin, cefuroxime, cefoxitin, gentamicin, sulfamethoxazole + trimethoprim, colistin, oxolinic acid, ofloxacin, tetracycline, and aztreonam during their cultivation at 23 °C and 36.5 °C. Ninety-six-well inoculated microplates with tested antibiotics in Mueller-Hinton broth were cultured under standard incubator conditions (normobaric normoxia) for 24 h or in an experimental hyperbaric chamber (HAUX, Germany) for 24 h at 2.8 ATA of 100% oxygen (hyperbaric hyperoxia). The hyperbaric chamber was pressurised with pure oxygen (100%). Both cultures (normoxic and hyperoxic) were carried out at 23 °C and 36.5 °C to study the possible effect of the cultivation temperature. No significant differences were observed between 23 and 36.5 °C cultivation with or without the 2-h lag phase in Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Cultivation in a hyperbaric chamber at 23 °C and 36.5 °C with or without a 2-h lag phase did not produce significant changes in the minimum inhibitory concentration (MIC) of Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. For the tested strains of Pseudomonas aeruginosa, the possible effect of hyperbaric oxygen on their antibiotic sensitivity could not be detected because the growth of these bacteria was completely inhibited by 100% hyperbaric oxygen at 2.8 ATA under all hyperbaric conditions tested at 23 °C and 36.5 °C. Subsequent tests with wild strains of pseudomonads, burkholderias, and stenotrophomonads not only confirmed the fact that these bacteria stop growing under hyperbaric conditions at a pressure of 2.8 ATA of 100% oxygen but also indicated that inhibition of growth of these bacteria under hyperbaric conditions is reversible.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24003880
- 003
- CZ-PrNML
- 005
- 20240305161718.0
- 007
- ta
- 008
- 240305s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12223-023-01120-5 $2 doi
- 035 __
- $a (PubMed)38100018
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Chmelař, Dittmar $u Institute of Laboratory Medicine, Institute of Microbiology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Centre for Hyperbaric Medicine of Faculty of Medicine and Ostrava City Hospital, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 245 10
- $a Effect of hyperbaric oxygen on the growth and susceptibility of facultatively anaerobic bacteria and bacteria with oxidative metabolism to selected antibiotics / $c D. Chmelař, M. Rozložník, M. Hájek, N. Pospíšilová, J. Kuzma
- 520 9_
- $a Wild strains of Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis were tested in an experimental hyperbaric chamber to determine the possible effect of hyperbaric oxygen on the susceptibility of these strains to the antibiotics ampicillin, ampicillin + sulbactam, cefazolin, cefuroxime, cefoxitin, gentamicin, sulfamethoxazole + trimethoprim, colistin, oxolinic acid, ofloxacin, tetracycline, and aztreonam during their cultivation at 23 °C and 36.5 °C. Ninety-six-well inoculated microplates with tested antibiotics in Mueller-Hinton broth were cultured under standard incubator conditions (normobaric normoxia) for 24 h or in an experimental hyperbaric chamber (HAUX, Germany) for 24 h at 2.8 ATA of 100% oxygen (hyperbaric hyperoxia). The hyperbaric chamber was pressurised with pure oxygen (100%). Both cultures (normoxic and hyperoxic) were carried out at 23 °C and 36.5 °C to study the possible effect of the cultivation temperature. No significant differences were observed between 23 and 36.5 °C cultivation with or without the 2-h lag phase in Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Cultivation in a hyperbaric chamber at 23 °C and 36.5 °C with or without a 2-h lag phase did not produce significant changes in the minimum inhibitory concentration (MIC) of Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. For the tested strains of Pseudomonas aeruginosa, the possible effect of hyperbaric oxygen on their antibiotic sensitivity could not be detected because the growth of these bacteria was completely inhibited by 100% hyperbaric oxygen at 2.8 ATA under all hyperbaric conditions tested at 23 °C and 36.5 °C. Subsequent tests with wild strains of pseudomonads, burkholderias, and stenotrophomonads not only confirmed the fact that these bacteria stop growing under hyperbaric conditions at a pressure of 2.8 ATA of 100% oxygen but also indicated that inhibition of growth of these bacteria under hyperbaric conditions is reversible.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 12
- $a hyperbarická oxygenace $7 D006931
- 650 _2
- $a anaerobní bakterie $7 D001421
- 650 _2
- $a kyslík $7 D010100
- 650 _2
- $a Bacteria $7 D001419
- 650 _2
- $a Pseudomonas aeruginosa $7 D011550
- 650 _2
- $a ampicilin $x farmakologie $7 D000667
- 650 _2
- $a Escherichia coli $7 D004926
- 650 _2
- $a kombinace léků trimethoprim a sulfamethoxazol $x farmakologie $7 D015662
- 650 _2
- $a Klebsiella pneumoniae $7 D007711
- 650 12
- $a pseudomonádové infekce $7 D011552
- 650 _2
- $a oxidační stres $7 D018384
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a sulbaktam $7 D013407
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Rozložník, Miroslav $u Institute of Laboratory Medicine, Institute of Microbiology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Centre for Hyperbaric Medicine of Faculty of Medicine and Ostrava City Hospital, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Hájek, Michal $u Institute of Laboratory Medicine, Institute of Microbiology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. michalhajek@email.cz $u Centre for Hyperbaric Medicine of Faculty of Medicine and Ostrava City Hospital, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. michalhajek@email.cz $u Centre of Hyperbaric Medicine, Ostrava City Hospital, Nemocnicni 20, Ostrava, 728 80, Czech Republic. michalhajek@email.cz $1 https://orcid.org/0000000310178470 $7 xx0089812
- 700 1_
- $a Pospíšilová, Nikol $u Institute of Laboratory Medicine, Institute of Microbiology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Kuzma, Jozef $u Institute of Laboratory Medicine, Institute of Microbiology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 69, č. 1 (2024), s. 101-108
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38100018 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240305 $b ABA008
- 991 __
- $a 20240305161714 $b ABA008
- 999 __
- $a ok $b bmc $g 2059329 $s 1213632
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 69 $c 1 $d 101-108 $e 20231215 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
- LZP __
- $a Pubmed-20240305